Related Experiment Video
Updated: Feb 5, 2026
05:58
Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens
Published on: February 4, 2014
14.2K
Pediatric Primary Ovarian Angiosarcoma: From Rarity to a Realization
Priyakumari Thankamony1, Rumesh Chandar1, Jayasree Kattoor2
1Department of Pediatric Oncology, Regional Cancer Centre, Trivandrum, Kerala, India.
Journal of Pediatric and Adolescent Gynecology
|September 5, 2018
Summary
Primary ovarian angiosarcoma is a rare high-grade sarcoma in children. Early diagnosis and treatment are crucial for a better outcome in these uncommon pediatric ovarian tumors.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Gynecologic Oncology
Background:
- Angiosarcoma is a rare, high-grade pediatric sarcoma.
- Visceral involvement, particularly ovarian, is exceptionally uncommon.
- Lack of recurrent cytogenetic alterations complicates histopathological diagnosis.
Observation:
- A case of primary angiosarcoma of the ovary in an 11-year-old prepubertal girl is presented.
- This highlights an unusual site for this rare pediatric malignancy.
Findings:
- Histopathological expertise is critical for diagnosing angiosarcoma in atypical locations like the ovary.
- Complete surgical resection and radiotherapy are primary treatment modalities.
- Chemotherapy plays a limited role in managing this condition.
Implications:
- Recognizing rare presentations of angiosarcoma is essential for timely and effective treatment.
- Improved diagnostic awareness can lead to better survival outcomes for pediatric patients.
- Further research into management strategies for rare pediatric sarcomas is warranted.
Related Concept Videos
01:27Ovarian Cycle
4.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.0K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
236
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
01:30Hormonal Control of the Ovarian Cycle
6.9K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.9K